Condition
Polymyalgia Rheumatica clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Polymyalgia Rheumatica clinical trials that are recruiting, at sites in 12 countries (most in United States (3), Denmark (2), Germany (2)). By phase: Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 12Countries
Newest Polymyalgia Rheumatica clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sarilumab for early polymyalgia rheumatica in adults | Phase 3 | Avondale, Arizona and 84 other locations | Recruiting | Dec 16, 2025 |
| Understanding the impact of immune-related side effects in arthritis patients after immunotherapy | — | Houston, Texas | Recruiting | Oct 17, 2024 |
| Understanding biomarkers in giant cell arteritis and polymyalgia rheumatica | — | Bonn, North Rhine-Westphalia | Recruiting | Jun 14, 2024 |
| National database for Giant Cell Arteritis and Polymyalgia Rheumatica | — | Aarhus and 1 other locations | Recruiting | Jul 7, 2023 |
| Supplemental hydrocortisone for adrenal insufficiency during stress | Phase 4 | Aarhus and 2 other locations | Recruiting | Jun 28, 2022 |
| Registry and biorepository for rheumatic diseases | — | New Haven, Connecticut | Recruiting | May 26, 2020 |
| Understanding genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica | — | Canterbury, Kent and 75 other locations | Recruiting | Sep 25, 2019 |
All recruiting trials (7)
-
Sarilumab for early polymyalgia rheumatica in adults
This study tests whether sarilumab given every two weeks, with a prednisone taper, helps people with early polymyalgia rheumatica more than placebo plus prednisone taper.
-
Understanding the impact of immune-related side effects in arthritis patients after immunotherapy
This study looks at how immune-related side effects from immunotherapy affect the daily lives of arthritis patients and what they think about these experiences.
-
Understanding biomarkers in giant cell arteritis and polymyalgia rheumatica
This study is trying to find specific markers in the blood of people newly diagnosed with giant cell arteritis and polymyalgia rheumatica to help doctors understand their disease better and create personalized treatment plans.
-
National database for Giant Cell Arteritis and Polymyalgia Rheumatica
This study is trying to see how new imaging techniques can help doctors better manage Giant Cell Arteritis and Polymyalgia Rheumatica by looking at treatment responses and risks in patients.
-
Supplemental hydrocortisone for adrenal insufficiency during stress
This study is testing if adding hydrocortisone can help people with polymyalgia rheumatica or giant cell arteritis who have low adrenal function feel better during stressful times compared to a placebo.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
Understanding genetic factors in Giant Cell Arteritis and Polymyalgia Rheumatica
This study is trying to find out if certain genes make people more likely to get Giant Cell Arteritis or Polymyalgia Rheumatica, focusing on patients aged 50 and older who have these conditions.
Related topics
Quick answers
How many Polymyalgia Rheumatica clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (3 trials), Denmark (2 trials), Germany (2 trials), United Kingdom (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.